FDG PET reimbursement.

Today, PET is increasingly accepted as a crucial imaging modality for early detection of disease, precise staging of disease progression, and accurate assessment of the effects of therapy. As the role of PET continues to emerge, so do questions regarding PET reimbursement. Understanding the complexities and complying with reimbursement policies, procedures, and interpretation of payer programs is key to receiving appropriate reimbursement for services performed. Therefore, it is imperative that facilities stay current on reimbursement issues—especially for a fast-evolving modality like PET, where indications and policies for reimbursement are continually being updated by the Centers for Medicare and Medicaid Services (CMS).